Humanae vitae, ideología de género y futuro biotecnológico

José María Murcia Lora

doi:10.5294/pebi.2018.22.2.11

Autores

José María Murcia Lora Autor Consulta Privada en España http://orcid.org/0000-0003-0511-0578

DOI:

https://doi.org/10.5294/pebi.2018.22.2.11

Palavras-chave:

Ideologia de género, identidade de gênero, LGTB, LGTBI, Humanae Vitae, antropologia da sexualidade, biotecnologia, biomarcador, janela fértil, reconhecimento da fertilidade, ovulação

Resumo

Humanae vitae, ideología de género y futuro biotecnológico

Humanae Vitae, Gender Ideology and Biotechnological Future

Este pequeno artigo visa fazer um breve comentário aludindo à influência da Humanae vitae, cinquenta anos depois de ter sido publicada. Nesse contexto, alguns aspectos relacionados à influência positiva que a Humanae vitae confere ao ambiente afetivo da sexualidade são discutidos, tanto na idade adulta quanto nos primeiros anos da juventude, diante da influência da ideologia LGTBI. A visão antropológica da sexualidade confere um ambiente de respeito à dignidade da pessoa, diante de desvios que podem surgir devido à influência da ideologia de gênero. Por fim, são citados alguns artigos científicos internacionais, que ilustram positivamente a possibilidade de compatibilizar a ciência com o caráter unitivo e procriador da Humanae vitae, em um entorno globalizado.

Para citar este artículo / To reference this article / Para citar este artigo

Murcia-Lora JM. Humanae vitae, ideología de género y futuro biotecnológico. pers. bioét. 2018; 22(2): 358-366. DOI: 10.5294/pebi.2018.22.2.11

Downloads

Não há dados estatísticos.

Referências

Sedgh G et al. Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet. 2016;388(10041):258-67. DOI: 10.1016/S0140-6736(16)30380-4

Elnashar AM, Aboul-Enein GI. Endometrial receptivity. Mid East Fertil Soc J. 2004;9(1):10-24. Disponible en: http://www.bioline.org.br/pdf?mf04003

Noci I, Marchionni M, Fambrini M, Cioni R, Scarselli G. Fertilisation and implantation failure in an oral contraceptive user. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):73-5. DOI: 10.1016/S0301-2115(02)00054-4

Wilks J. El impacto de la píldora en los factores de la implantación. Nuevos descubrimientos de la investigación científica. Ethics Med. 2000;16(1):15-22. Disponible en: http://contracepcion.info/ETHMEDS.PDF

Ganatra B, Gerdts C, Rossier C, et al. Global, regional, and subregional classification of abortions by safety, 2010-14: Estimates from a Bayesian hierarchical model. Lancet. 2017; 90: 2372-81. DOI: 10.1016/S0140-6736(17)31794-4.

Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 1998;77:239-43. DOI: 10.1016/S0301-2115(97)00263-7

Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102:767-72. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/7547731

Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346:731-7. DOI: 10.1056/NEJMoa010806

Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 2002;346:725-30. DOI: 10.1056/NEJMoa010035

Stromberg B, Dahlquist G, Ericson A, Finnstrom O, Koster M, Stjernqvist K. Neurological sequelae in children born after in-vitro fertilisation: A population-based study. Lancet. 2002;359:461-5. DOI: 10.1016/S0140-6736(02)07674-2

The ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 2000;15:1856-64. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10920117

Schieve LA, Peterson HB, Meikle SF, et al. Live- birth rates and multiple-birth risk using in vitro fertilization. JAMA. 1999;282:1832-8. DOI: 10.1001/jama.282.19.1832

Loredo-Abdalá A, Vargas-Campuzano E, Casas-Muñoz A, González-Corona J, Gutiérrez-Leyva CJ. Adolescent pregnancy: Its causes and repercussions in the dyad. Rev Med Inst Mex Seguro Soc. 2017;55(2):223-9. Disponible en: http://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=71939

Shah I, Ahman E. Unsafe abortion: global and regional incidence, trends, consequences, and challenges. J Obstetr Gynaecol Can. 2009;31(12):1149-58. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S1701216316343766.pdf?locale=es_ES

Bruce MC. Embriología humana y biología del desarrollo. 5 ed. Elsevier: Barcelona; 2014.

Speroff L, Fritz MA. Regulación del ciclo menstrual. Endocrinología ginecológica clínica y esterilidad. 7 ed. Lippincott Williams & Wlilkins; 2006.

Gotzon M. Saber amar con el cuerpo. 7 ed. Madrid: Palabra; 2005.

Pablo VI. Carta encíclica Humanae vitae. Ciudad del Vaticano: Editrice Vaticana; 1968.

Evangelio según San Marcos 10, 8-12.

Alexander H, Kaczmarczyk M, Pretzsch G, Kersken GT, Puschmann D, Schiwek E, et al. The 2nd Biomarker Meeting in Personalized Reproductive Medicine. Continuous Measurements of Core Body Temperature as Biomarker for Ovulation Diagnosis. 085 Poster Valencia-Web. España; 2014.

Su HW, Yi YC, Wei TY, Chang TC, Cheng CM. Detection of ovulation, a review of currently available methods. AIChE Bioeng Trans Med. 2017;2:238-46. DOI: 10.1002/btm2.10058

WO2018178753 – 2018 10 04. Biosensor for Biophysical Measurement of Cervical Secretion.

Keulers MJ, Hamilton CJ, Franx A, Evers JL, Bots RS. The length of the fertile window is associated with the chance of spontaneously conceiving an ongoing pregnancy in subfertile couples. Hum Reprod. 2007;22(6):1652-56. DOI: 10.1093/humrep/dem051

Simon C, Sakkas D, Gardner DK, Critchley HO. Biomarkers in reproductive medicine: The quest for new answers. Hum Reprod. 2015;21(6):6957. DOI: 10.1093/humupd/dmv043

Thijssen A, Meier A, Panis K, Ombelet W. Fertility awareness-based methods’ and subfertility: A systematic review. Facts Views Vis Obgyn. 2014,6(3):113-23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216977/

Sharma N. Challenges in the field of biomedical engineering research. Op Acc J Bio Eng Bio Sci. 2018;2(1):OAJBEB.MS.ID.000128. DOI: 10.32474/OAJBEB.2018.02.000128

Hilgers TW. The Medical & Surgical Practice of NaProTechnology. Nebraska: Pope Paul VI Institute Press.

Scarpa et al. Cervical mucus secretions on the day of intercourse: An accurate marker of highly fertile days. Europ J Obstet Gyneco Reprod Biol. 2006;125:72-8. DOI: 10.1016/j.ejogrb.2005.07.024

Murcia LJM, Mejía QJE, Falces de A. Fertility awareness and biotechnological application by innovation networks. Int Gyn & Women’s Health. 2018;2(3). IGWHC.MS.ID.000144. DOI: 10.32474/IGWHC.2018.02.000136

Murcia Lora JM. Biophysical biomarkers of the fertile window in sub-fertile women: Individual approach. Int Gyn & Women’s Health. 2018;2(4). IGWHC.MS.ID.000144. DOI: 10.32474/IGWHC.2018.02.000144

Murcia Lora JM. Clinical Biomarkers and Biotechnology in Fertile Window. Int Gyn & Women’s Health. 2018;2(2). IGWHC.MS.ID.000135 DOI: 10.32474/IGWHC.2018.02.000135